Earnings History Data for Dyne Therapeutics, Inc. (DYN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Dyne Therapeutics, Inc.
Dyne Therapeutics Inc. is a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases. The company's proprietary platform includes FORCE(TM). Dyne Therapeutics Inc. is based in WALTHAM, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2024 | PM | DYN | Dyne Therapeutics, Inc. | 2,940 | -0.96 | -0.71 | -0.99 | Dyne Therapeutics GAAP EPS of -$0.96 misses by $0.25 [11/12/2024 9:02 AM] |
29.32 | 1.19 (4.23%) |
29.49 | 1.36 (4.83%) |
8.05 - 47.45 | 1,677,063 | 940,000 | 811 | ||
| 12-08-2024 | PM | DYN | Dyne Therapeutics | 3,764 | -0.70 | -0.72 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.70 misses by $0.02 [8/13/2024 2:03 AM] |
43.52 | 0.45 (1.04%) |
43.07 | 0.0 (0.00%) |
6.40 - 45.46 | 752,131 | 980,000 | 19,315 | ||
| 02-05-2024 | PM | DYN | Dyne Therapeutics | 2,181 | -0.81 | -0.81 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.81 misses by $0.01 [5/3/2024 1:58 AM] |
26.09 | 0.09 (0.35%) |
26.00 | 0.0 (0.00%) |
6.40 - 30.27 | 622,732 | 820,000 | 28,863 | ||
| 05-03-2024 | PM | DYN | Dyne Therapeutics | 1,788 | -1.09 | -0.92 | 0.00 | Dyne Therapeutics GAAP EPS of -$1.09 misses by $0.17 [3/5/2024 7:37 AM] |
25.88 | -1.83 (-6.60%) |
28.00 | 0.29 (1.05%) |
6.40 - 30.27 | 1,035,898 | 1,490,000 | 800 | ||
| 30-10-2023 | PM | DYN | Dyne Therapeutics | 419.00 | -0.99 | -0.86 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.99 misses by $0.16 [10/30/2023 7:34 AM] |
7.29 | 0.67 (10.12%) |
0.0 | 0.0 (0.00%) |
6.40 - 15.60 | 625,788 | 440,000 | 0 | ||
| 11-05-2023 | PM | DYN | Dyne Therapeutics | 833.00 | -0.78 | -0.77 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.78 misses by $0.01 [5/11/2023 11:55 AM] |
13.64 | -0.35 (-2.54%) |
0.0 | 0.0 (0.00%) |
4.30 - 15.63 | 320,061 | 590,000 | 0 | ||
| 02-03-2023 | PM | 7:30 AM ET (Mar 2) |
DYN | Dyne Therapeutics | 671.00 | -0.74 | -0.84 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.74 beats by $0.11 [3/2/2023 8:45 AM] |
14.40 | 0.77 (5.65%) |
13.80 | 0.17 (1.25%) |
4.30 - 15.63 | 397,262 | 260,000 | 345 | |
| 02-05-2022 | AH | DYN | Dyne Therapeutics | 419.00 | -0.69 | -0.88 | 0.00 | Dyne Therapeutics GAAP EPS of -$0.69 [5/2/2022 4:58 PM] |
8.89 | 0.37 (4.34%) |
8.52 | 0.0 (0.00%) |
6.39 - 22.92 | 181,848 | 164,035 | 11,775 | ||
| 06-05-2021 | PM | 7:35 AM ET (May 6) |
DYN | Dyne Therapeutics, Inc. | 903.00 | -0.50 | -0.60 | 0.00 | Dyne Therapeutics EPS beats by $0.10 [5/6/2021 8:10 AM] |
18.12 | 0.32 (1.80%) |
18.12 | 0.0 (0.00%) |
13.50 - 32.31 | 169,593 | 240,000 | 705 | |
| 04-03-2021 | PM | DYN | Dyne Therapeutics, Inc. | 914.21 | -0.64 | -0.38 | 0.00 | Dyne Therapeutics EPS misses by $0.26 [3/4/2021 8:40 AM] |
15.66 | -1.02 (-6.15%) |
16.54 | -0.14 (-0.84%) |
14.94 - 32.32 | 312,592 | 363,112 | 1,052 | ||